Concepedia

Vanessa Taylor

VT

29

Publications

1.8K

Citations

20

H-Index

1996

Active since

Affiliations

Rigel (United States)(Current)

Sunesis (United States)

University of Birmingham

John Radcliffe Hospital

University of Bradford

Vanessa Taylor is an author at Rigel (United States) specializing in medicine, cell signaling, and signal transduction.

Top concepts

Publications per year

1996–2024

29

Publications

29

R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation

Sylvia Braselmann, Vanessa Taylor, H. Zhao et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 508 citations

The Myeloid-specific Sialic Acid-binding Receptor, CD33, Associates with the Protein-tyrosine Phosphatases, SHP-1 and SHP-2

Vanessa Taylor, Christopher D. Buckley, Michael E. Douglas et al. · Journal of Biological Chemistry · 1999 · 186 citations · Full text

5′ Phospholipid Phosphatase SHIP-2 Causes Protein Kinase B Inactivation and Cell Cycle Arrest in Glioblastoma Cells

Vanessa Taylor, Michelle Wong, Christian Brandts et al. · Molecular and Cellular Biology · 2000 · 183 citations · Full text

Differential association of cytoplasmic signalling molecules SHP‐1, SHP‐2, SHIP and phospholipase C‐γ1 with PECAM‐1/CD31

Nicholas J. Pumphrey, Vanessa Taylor, Sylvie Freeman et al. · FEBS Letters · 1999 · 102 citations · Full text

Homophilic PECAM-1(CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration

Ian N. Bird, Vanessa Taylor, Justin P. Newton et al. · Journal of Cell Science · 1999 · 82 citations

Rows per page

1–5 of 29